![](/img/cover-not-exists.png)
Bortezomib-based chemotherapy can improve renal and tubular functions in patients with light chain-associated Fanconi syndrome
Wu, Xia, Zhang, Lu, Feng, Jun, Mao, Yue-ying, Cao, Xin-xin, Zhou, Dao-bin, Li, JianLanguage:
english
Journal:
Annals of Hematology
DOI:
10.1007/s00277-018-3572-6
Date:
December, 2018
File:
PDF, 539 KB
english, 2018